59.35
price down icon1.88%   -1.14
after-market アフターアワーズ: 59.50 0.15 +0.25%
loading
前日終値:
$60.49
開ける:
$59.34
24時間の取引高:
3.91M
Relative Volume:
1.72
時価総額:
$9.46B
収益:
$705.14M
当期純損益:
$-453.90M
株価収益率:
-19.52
EPS:
-3.04
ネットキャッシュフロー:
$-551.29M
1週間 パフォーマンス:
+39.25%
1か月 パフォーマンス:
+36.59%
6か月 パフォーマンス:
+80.12%
1年 パフォーマンス:
+24.55%
1日の値動き範囲:
Value
$58.84
$60.75
1週間の範囲:
Value
$42.13
$62.08
52週間の値動き範囲:
Value
$23.95
$62.08

Ionis Pharmaceuticals Inc Stock (IONS) Company Profile

Name
名前
Ionis Pharmaceuticals Inc
Name
セクター
Healthcare (1151)
Name
電話
(760) 931-9200
Name
住所
2855 GAZELLE COURT, CARLSBAD, CA
Name
職員
927
Name
Twitter
@ionispharma
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
IONS's Discussions on Twitter

IONS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
IONS
Ionis Pharmaceuticals Inc
59.35 9.16B 705.14M -453.90M -551.29M -3.04
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Ionis Pharmaceuticals Inc Stock (IONS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-31 アップグレード Morgan Stanley Equal-Weight → Overweight
2025-07-01 アップグレード Barclays Equal Weight → Overweight
2025-04-07 開始されました H.C. Wainwright Buy
2025-03-31 開始されました Redburn Atlantic Neutral
2024-08-02 ダウングレード BMO Capital Markets Outperform → Market Perform
2024-07-24 アップグレード Leerink Partners Market Perform → Outperform
2024-07-16 再開されました Jefferies Buy
2024-06-14 アップグレード Bernstein Underperform → Mkt Perform
2024-04-10 アップグレード Wolfe Research Peer Perform → Outperform
2024-01-02 アップグレード BofA Securities Neutral → Buy
2023-10-23 アップグレード BofA Securities Underperform → Neutral
2023-09-29 開始されました Raymond James Strong Buy
2023-07-31 アップグレード Citigroup Neutral → Buy
2023-06-07 再開されました Piper Sandler Overweight
2023-05-04 アップグレード Citigroup Sell → Neutral
2023-03-21 開始されました Bernstein Underperform
2022-12-21 ダウングレード Morgan Stanley Overweight → Equal-Weight
2022-09-09 再開されました Morgan Stanley Overweight
2022-07-18 再開されました Oppenheimer Outperform
2022-03-31 再開されました Piper Sandler Overweight
2022-03-01 開始されました Citigroup Sell
2022-03-01 開始されました Guggenheim Buy
2022-02-01 ダウングレード BofA Securities Buy → Underperform
2021-12-14 アップグレード William Blair Mkt Perform → Outperform
2021-05-07 アップグレード UBS Sell → Neutral
2021-03-01 アップグレード Barclays Underweight → Equal Weight
2020-12-16 開始されました UBS Sell
2020-12-15 アップグレード Cowen Market Perform → Outperform
2020-09-14 再開されました JP Morgan Neutral
2020-09-02 開始されました The Benchmark Company Hold
2020-06-01 再開されました Oppenheimer Outperform
2020-05-13 開始されました RBC Capital Mkts Outperform
2020-03-05 開始されました Citigroup Buy
2019-12-13 開始されました Oppenheimer Outperform
2019-11-13 開始されました BofA/Merrill Buy
2019-11-07 ダウングレード Morgan Stanley Equal-Weight → Underweight
2019-09-10 アップグレード Bernstein Mkt Perform → Outperform
2018-08-08 繰り返されました Stifel Hold
2018-08-07 繰り返されました Stifel Hold
2018-05-08 ダウングレード Evercore ISI Outperform → In-line
2017-10-06 再開されました Goldman Sell
2017-08-17 開始されました Evercore ISI Outperform
2017-08-09 繰り返されました Stifel Hold
2017-03-10 ダウングレード Goldman Neutral → Sell
2016-12-28 繰り返されました BMO Capital Markets Outperform
2016-12-27 繰り返されました Leerink Partners Mkt Perform
すべてを表示

Ionis Pharmaceuticals Inc (IONS) 最新ニュース

pulisher
09:46 AM

Ionis Pharmaceuticals CEO Monia sells $12.3 million in IONS stock - Investing.com

09:46 AM
pulisher
09:41 AM

Ionis pharma EVP O’Neil sells $5.39 million in IONS stock - Investing.com

09:41 AM
pulisher
09:25 AM

Ionis Pharma EVP Geary sells $503,671 in IONS stock - Investing.com

09:25 AM
pulisher
09:24 AM

Ionis Pharmaceuticals director sells $1.6m in IONS stock - Investing.com

09:24 AM
pulisher
09:21 AM

Ionis Pharma director Klein sells $1.68 million in shares - Investing.com

09:21 AM
pulisher
03:31 AM

Ionis Pharma (IONS) Hits New High Anew as Analyst Sees Blockbuster Potential for Olezarsen - Yahoo Finance

03:31 AM
pulisher
01:57 AM

Ionis Pharmaceuticals’ Strategic Position in the Biotech Sector: Growth Potential in Therapeutic Innovation and Market Leadership - AInvest

01:57 AM
pulisher
09:38 AM

What drives Ionis Pharmaceuticals Inc.’s stock price2025 Volume Leaders & Proven Capital Preservation Methods - khodrobank.com

09:38 AM
pulisher
09:30 AM

Is Ionis Pharmaceuticals Inc. forming a double bottomWeekly Trading Summary & AI Based Trade Execution Alerts - khodrobank.com

09:30 AM
pulisher
08:30 AM

RBC Capital Adjusts Price Target on Ionis Pharmaceuticals to $80 From $70, Maintains Outperform Rating - MarketScreener

08:30 AM
pulisher
07:33 AM

How to use a screener to detect Ionis Pharmaceuticals Inc. breakoutsWeekly Stock Summary & Daily Volume Surge Signals - Newser

07:33 AM
pulisher
07:07 AM

When is the best time to exit Ionis Pharmaceuticals Inc.July 2025 Momentum & Fast Entry High Yield Stock Tips - Newser

07:07 AM
pulisher
04:48 AM

Market reaction to Ionis Pharmaceuticals Inc.’s recent newsMarket Trend Summary & Reliable Momentum Entry Alerts - Newser

04:48 AM
pulisher
01:02 AM

What’s next for Ionis Pharmaceuticals Inc. stock priceDollar Strength & Community Driven Trade Alerts - Newser

01:02 AM
pulisher
Sep 03, 2025

Street Watch: Is Ionis Pharmaceuticals Inc. a cyclical or defensive stockJuly 2025 Catalysts & Consistent Profit Trade Alerts - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Ionis Pharmaceuticals Executives Buy Shares Amid Recent Market Volatility. - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Amyotrophic Lateral Sclerosis Pipeline Outlook 2025: Clinical - openPR.com

Sep 03, 2025
pulisher
Sep 03, 2025

Ionis Pharmaceuticals Shares Rise After BMO Capital Upgrade - MarketScreener

Sep 03, 2025
pulisher
Sep 03, 2025

Key resistance and support levels for Ionis Pharmaceuticals Inc.M&A Rumor & Daily Stock Trend Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What the charts say about Ionis Pharmaceuticals Inc. todayQuarterly Profit Report & Free Weekly Watchlist of Top Performers - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Citigroup maintains Buy rating, raises Ionis Pharmaceuticals PT to $84 from $69. - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Is Ionis Pharmaceuticals Inc. stock trending bullish2025 Breakouts & Breakdowns & High Accuracy Trade Signal Alerts - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Ionis Pharma (IONS) Touches New High on Promising Olezarsen Results - MSN

Sep 03, 2025
pulisher
Sep 03, 2025

IONS Hits 52-Week High on Tryngolza's Success in Lowering Triglyceride - Yahoo Finance

Sep 03, 2025
pulisher
Sep 03, 2025

Ionis Pharmaceuticals: BMO Capital Upgrades to Outperform, PT Raised to $70 - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Ionis Pharmaceuticals Soars: New Drug Approved - StocksToTrade

Sep 03, 2025
pulisher
Sep 03, 2025

Buy IONS Stock After Its 35% Pop? - Trefis

Sep 03, 2025
pulisher
Sep 03, 2025

Ionis upgraded at BMO Capital Markets after data for lipid-lowering agent - MSN

Sep 03, 2025
pulisher
Sep 03, 2025

Ionis stock upgraded at BMO Capital Markets (IONS:NASDAQ) - Seeking Alpha

Sep 03, 2025
pulisher
Sep 03, 2025

Analyzing Ionis Pharmaceuticals Inc. with risk reward ratio charts2025 Major Catalysts & Community Verified Swing Trade Signals - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Ionis Pharmaceuticals, Inc.'s (NASDAQ:IONS) 34% Share Price Surge Not Quite Adding Up - simplywall.st

Sep 03, 2025
pulisher
Sep 03, 2025

Using data filters to optimize entry into Ionis Pharmaceuticals Inc.Buy Signal & Accurate Entry/Exit Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Ionis Pharmaceuticals Inc. stock prediction for this week2025 Support & Resistance & Low Risk Profit Maximizing Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

MSD, Ionis trumpet lipid-lowering drug data - pharmaphorum

Sep 03, 2025
pulisher
Sep 03, 2025

Ionis Pharmaceuticals stock rating upgraded by BMO Capital on blockbuster potential - Investing.com

Sep 03, 2025
pulisher
Sep 03, 2025

BMO Capital Upgrades Ionis Pharmaceuticals to Outperform From Market Perform, Adjusts PT to $70 From $40 - MarketScreener

Sep 03, 2025
pulisher
Sep 03, 2025

Will Ionis Pharmaceuticals Inc. bounce back from current supportPortfolio Value Report & Expert Approved Momentum Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Ionis reports topline outcomes from Phase III trials of olezarsen for sHTG - Yahoo Finance

Sep 03, 2025
pulisher
Sep 03, 2025

Ionis Pharmaceuticals shares rise 1.74% premarket after positive Phase 3 study results for olezarsen. - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Has Ionis Pharmaceuticals Inc. formed a bullish divergenceBuy Signal & Fast Entry Momentum Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Ionis to present at upcoming September 2025 investor conferences - BioSpace

Sep 03, 2025
pulisher
Sep 03, 2025

What are Ionis Pharmaceuticals Inc.’s earnings expectationsRecession Risk & Trade Opportunity Analysis Reports - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Comparing Ionis Pharmaceuticals Inc. in custom built stock radarsWeekly Profit Summary & AI Optimized Trade Strategies - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Ionis looks to expand use of lipid-lowering drug after trial hits goal - BioPharma Dive

Sep 02, 2025
pulisher
Sep 02, 2025

Narrow-Moat Ionis Expands Its Cardiology and Neurology Portfolio; Positive Long-Term Outlook - Morningstar

Sep 02, 2025
pulisher
Sep 02, 2025

Visualizing Ionis Pharmaceuticals Inc. stock with heatmaps2025 Top Gainers & Daily Profit Maximizing Tips - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Ionis reports sHTG win while Arrowhead inks Novartis deal - BioWorld MedTech

Sep 02, 2025
pulisher
Sep 02, 2025

IONS Stock Soars: Time to Buy or Stay Cautious? - timothysykes.com

Sep 02, 2025
pulisher
Sep 02, 2025

More Ways to Cut Cholesterol, Triglycerides Are Coming. This Stock Took Off. - Barron's

Sep 02, 2025
pulisher
Sep 02, 2025

Ionis Looks Set To Own Its First Blockbuster - insights.citeline.com

Sep 02, 2025
pulisher
Sep 02, 2025

Ionis to present at upcoming investor conferences - Business Wire

Sep 02, 2025

Ionis Pharmaceuticals Inc (IONS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
大文字化:     |  ボリューム (24 時間):